Parata's COVID-19 Response

Read time: 3 minutes 22 seconds

PQA presents: When the Stars Align

Prepare Your Pharmacy for Success

McKesson ideaShare got off to a great start Monday in sunny Orlando, and the Parata team is happy to be here!

It was standing room only during our sponsored Lunch and Learn session with Sam Stolpe, PharmD, Director of Quality Strategies at the Pharmacy Quality Alliance (PQA), and a Next-Generation Pharmacist Rising Star of the year finalist. As a member of PQA, we appreciate the leadership by Sam, the core team and work group leaders as they work to improve the quality of medication management and patient health.

Sam talked about the Triple Aim — better health, better care, lower cost — of the nation’s efforts to improve our health care system. In addition, he explained how pharmacists can prepare for success in building new payer and provider relationships by understanding the CMS (Centers for Medicaid and Medicare Services) Star Ratings for Medicare plans. Parata was proud to sponsor the popular session with 50 available seats filled and a waiting list — and just wish we could have accommodated the other 30-plus ideaShare attendees who stood in line hoping for a spot.

Thanks to Michael Johnsen, senior editor with Drug Store News, those who weren’t able to hear Sam in person, can read about the session in the July 21 issue.  In his story, Preparing for the impact of pharmacy quality metrics, Michael reports that that the Five-Star Rating System “…already is impacting how pharmacies think about their patients and their medication adherence programs.”

That influence is only expected to grow as we shift from volume-based health care to a system that rewards the value of care delivered to patients. With nearly half the CMS Star Ratings based on medication management measures, pharmacists have an opportunity to contribute significantly to the quality ratings of health plans and certain provider groups. In fact, Sam explained, most Medicare Part D plans could move from three to four stars on each PDC (portion of days covered) measure if every pharmacy in its network improved the adherence of a single patient taking diabetes, blood pressure and cholesterol medications.

Members of the Parata team participate in PQA work groups — often alongside some of our customers — to contribute to PQA’s measure development process, a consensus-driven process used to draft, test, refine and endorse high-priority measures of medication-use quality. Medication therapy management is a key driver of patient health, and it’s no surprise the industry is turning to pharmacists to help improve patient health outcomes. Many of our innovative pharmacy technology customers are including adherence packaging as part of their MTM programs – and they say their patients are the real winners with an easier way to manage their health.

To read the full Drug Store News article, click here.

Other Stories You May Like